Aramark
ARMK
$56.88
+1.17%
Aramark is a global food service and facilities management company headquartered in Philadelphia, Pennsylvania, providing dining, catering, and support services to schools, healthcare facilities, businesses, and entertainment venues. As one of the largest players in the specialty business services industry, Aramark differentiates itself through its scale, diversified client base, and integrated service offerings across North America and internationally. The current investor narrative centers on the company's robust revenue growth, margin expansion efforts, and strategic focus on operational efficiency, which have driven a significant re-rating of the stock over the past year. Recent earnings beats and positive analyst actions have reinforced confidence in management's ability to sustain growth while navigating cost pressures and a competitive landscape.…
ARMK
Aramark
$56.88
Investment Opinion: Should I buy ARMK Today?
Based on the analysis, ARMK is rated a Buy. The thesis is that accelerating revenue growth and margin expansion will continue, driving earnings growth that justifies the current valuation. The consensus rating is 'Buy' with an average target of $60.19, implying 5.65% upside, which is modest but positive. The company's forward PE of 21.08x is in line with the industry, and its revenue growth of 14.68% outpaces the sector, supporting the premium.
Sign up to view all
ARMK 12-Month Price Forecast
The AI assessment is bullish, driven by strong fundamental momentum and reasonable valuation. The company's accelerating revenue growth and margin expansion are positive signals, and the forward PE suggests the market is pricing in achievable earnings growth. However, the high debt and thin margins warrant caution. The stance would be upgraded to high confidence if revenue growth sustains above 15% and margins continue to expand. Conversely, a downgrade to neutral would occur if growth decelerates below 10% or margins compress.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Aramark's 12-month outlook, with a consensus price target around $61.13 and implied upside of +7.5% versus the current price.
Average Target
$61.13
0 analysts
Implied Upside
+7.5%
vs. current price
Analyst Count
—
covering this stock
Price Range
$40 - $71
Analyst target range
Aramark is covered by 16 analysts, with a consensus recommendation of 'Buy' and a mean recommendation score of 1.56 (where 1 is Strong Buy and 5 is Sell). The average price target is $60.19, implying an upside of 5.65% from the current price of $56.97. The distribution of ratings is bullish, with no Sell ratings and a majority of Buy or Outperform ratings, including recent affirmations from Oppenheimer, Citigroup, and B of A Securities. The target price range spans from a low of $40.00 to a high of $70.50, indicating a wide dispersion of views. The low target suggests concerns about potential margin compression or competitive pressures, while the high target reflects optimism about continued growth and operational leverage. The recent ratings actions have been predominantly positive, with no downgrades, signaling that analysts are confident in the company's trajectory. The wide spread between the low and high targets highlights the uncertainty around the sustainability of growth and margin expansion, but the overall sentiment remains constructive.
Bulls vs Bears: ARMK Investment Factors
Aramark presents a compelling growth story with accelerating revenue, improving margins, and strong analyst support. The bull case is anchored by a 14.68% revenue growth and a 65% net income surge, while the bear case highlights high debt and thin margins. Currently, the bull case has stronger evidence, as the company is executing well operationally and the forward valuation is reasonable. The key tension is whether the company can sustain its margin expansion and revenue growth to justify the premium trailing PE. If it does, the stock could re-rate higher; if not, the stock may face a correction toward the low target of $40.
Bullish
- Accelerating Revenue Growth: Q2 FY2026 revenue grew 14.68% YoY to $4.91B, up from 5.7% growth in the prior year quarter, marking the third consecutive quarter of acceleration. This momentum is driven by strong performance in both U.S. and international segments, indicating broad-based demand.
- Margin Expansion Driving Profitability: Operating margin expanded to 4.48% from 4.07% a year ago, while net income surged 65% to $101.95M in Q2 FY2026. The company is successfully leveraging operational efficiencies and cost controls, improving bottom-line performance.
- Strong Analyst Support: With 16 analysts, the consensus is 'Buy' (mean score 1.56) and no Sell ratings. Recent affirmations from Oppenheimer, Citigroup, and B of A Securities underscore confidence, and the average price target of $60.19 implies 5.65% upside.
- Undervalued on Forward Earnings: The forward PE of 21.08x is in line with the industry average of 22x, despite a trailing PE of 31.45x. This suggests the market is pricing in strong earnings growth, which is supported by the company's margin trajectory.
Bearish
- High Debt Levels: Debt-to-equity ratio stands at 1.82, indicating significant leverage. This increases financial risk, especially if interest rates remain elevated, as interest expenses of $82.24M in Q2 FY2026 consume a large portion of operating income.
- Thin Gross Margins: Gross margin is only 5.98%, reflecting the cost-intensive nature of the food service industry. This leaves little room for error, and any cost inflation or pricing pressure could quickly erode profitability.
- Potential Overvaluation on Trailing PE: The trailing PE of 31.45x is 43% above the industry average of 22x. If earnings growth fails to meet expectations, the stock could face multiple compression, leading to a significant downside.
- Low Analyst Target Upside: The average price target of $60.19 offers only 5.65% upside, which is modest for a stock with a beta of 1.18. This suggests limited near-term appreciation potential, and the stock may be fairly valued at current levels.
ARMK Technical Analysis
Aramark's stock is in a strong uptrend, with a 1-year price change of +33.86%, significantly outperforming the S&P 500's +18.19% over the same period. The current price of $56.97 sits near the top of its 52-week range, at approximately 97% of the high of $58.68, indicating robust momentum and investor optimism. This positioning near highs suggests the market is rewarding the company's fundamental progress, though it also raises the risk of short-term overextension. The stock's beta of 1.18 implies slightly higher volatility than the market, which is important for risk management.
Beta
1.20
1.20x market volatility
Max Drawdown
-18.4%
Largest decline past year
52-Week Range
$35-$59
Price range past year
Annual Return
+43.8%
Cumulative gain past year
| Period | ARMK Return | S&P 500 |
|---|---|---|
| 1m | +1.6% | +2.5% |
| 3m | +26.2% | +5.2% |
| 6m | +46.9% | +11.5% |
| 1y | +43.8% | +22.6% |
| ytd | +55.5% | +12.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ARMK Fundamental Analysis
Aramark's revenue growth has been accelerating, with the most recent quarter (Q2 FY2026) reporting revenue of $4.91 billion, up 14.68% year-over-year, compared to a 5.7% growth in the prior year quarter. This marks the third consecutive quarter of accelerating growth, driven by strong performance in both the U.S. and international segments, with U.S. revenue of $3.43 billion and international revenue of $1.48 billion. The company's profitability is improving, with net income of $101.95 million in Q2 FY2026, up from $61.85 million in the same quarter last year, and a net margin of 2.08%, up from 1.45%. Gross margin, however, remains thin at 5.98%, reflecting the cost-intensive nature of the food service industry, but operating margin has expanded to 4.48% from 4.07% a year ago, indicating improved operational efficiency.
Quarterly Revenue
$4.9B
2026-04
Revenue YoY Growth
+14.7%
YoY Comparison
Gross Margin
6.0%
Latest Quarter
Free Cash Flow
$415947000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ARMK Overvalued?
Given Aramark's positive net income, the PE ratio is the most appropriate valuation metric. The trailing PE is 31.45x, while the forward PE is 21.08x, implying the market expects significant earnings growth ahead. This gap suggests that investors are pricing in a strong recovery in profitability, which is supported by the company's recent margin improvements. Compared to the industry average PE of 22x (based on available data), Aramark trades at a 43% premium on a trailing basis, but the forward PE is in line with the industry, indicating that the premium is justified by expected growth. Historically, Aramark's PE has ranged from 5.98x to 63.86x over the past few years, with the current trailing PE of 31.45x sitting near the middle of that range, suggesting there is room for further re-rating if the company continues to deliver on its growth and margin targets.
PE
31.5x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 6x~51x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
12.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financial risks are notable, with a debt-to-equity ratio of 1.82 and interest expenses of $82.24M in Q2 FY2026, which consume about 37% of operating income. The company's gross margin is razor-thin at 5.98%, leaving limited buffer against cost inflation. While net income is positive, the net margin of 2.08% is low, and any operational hiccup could quickly turn profits negative. The current ratio of 0.99 indicates potential liquidity concerns, as current liabilities slightly exceed current assets, which could strain short-term obligations if cash flow falters.
FAQ
The key risks are: 1) High debt levels (debt-to-equity of 1.82) increase financial risk, especially if interest rates rise. 2) Thin gross margins (5.98%) leave little room for cost inflation. 3) The stock's beta of 1.18 means it is more volatile than the market, and a macro downturn could hit it hard. 4) Competitive pressures could lead to contract losses, impacting revenue. The most severe risk is a combination of cost inflation and economic slowdown, which could compress margins and reduce demand, potentially leading to a drop to the 52-week low of $35.07.
The 12-month forecast is moderately bullish. The base case (50% probability) sees the stock trading around the average target of $60.19, implying 5.65% upside. The bull case (30% probability) targets $60.19-$70.50, driven by continued strong growth. The bear case (20% probability) could see the stock fall to $35.07-$40.00 if growth stalls or margins compress. The most likely scenario is the base case, assuming revenue growth remains in the 10-15% range and margins improve gradually.
ARMK's trailing PE of 31.45x is 43% above the industry average of 22x, suggesting it is overvalued on a historical basis. However, the forward PE of 21.08x is in line with the industry, indicating that the market expects significant earnings growth. The PEG ratio of 1.31 suggests the stock is fairly valued relative to its growth rate. Overall, the stock is not cheap, but the growth prospects justify the premium, making it fairly valued for a growth stock.
ARMK is a good buy for investors with a medium-term horizon, given its strong revenue growth and margin expansion. The stock has 5.65% upside to the average analyst target of $60.19, and the forward PE of 21.08x is in line with the industry, suggesting fair valuation. However, the high debt and thin margins are risks, and the stock is near its 52-week high, so a pullback could offer a better entry. For risk-tolerant investors, it's a buy; for conservative investors, waiting for a dip might be prudent.
ARMK is more suitable for long-term investment, given its growth trajectory and margin expansion potential. The stock has a beta of 1.18, indicating moderate volatility, and a dividend yield of 1.08%, providing some income. Short-term trading could be profitable given the momentum, but the modest upside to analyst targets suggests limited near-term gains. For long-term investors, a holding period of at least 3-5 years is recommended to fully realize the benefits of earnings growth and potential re-rating.